Introduction: Antithrombotic therapy - The evolving consensus - 1985 to 1998

被引:28
作者
Dalen, JE [1 ]
Hirsh, J [1 ]
机构
[1] Univ Arizona, Tucson, AZ 85724 USA
关键词
D O I
10.1378/chest.114.5_Supplement.439S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:439S / 440S
页数:2
相关论文
共 11 条
[1]   ATRIAL-FIBRILLATION AND STROKE - 3 NEW STUDIES, 3 REMAINING QUESTIONS [J].
ALBERS, GW .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) :1443-1448
[2]  
[Anonymous], 1986, CHEST S, V89, p1S
[3]  
BARRITT DW, 1960, LANCET, V1, P1309
[4]  
Blackshear JL, 1996, LANCET, V348, P633
[5]   An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation [J].
Hylek, EM ;
Skates, SJ ;
Sheehan, MA ;
Singer, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) :540-546
[6]  
MCBRIDE R, 1994, LANCET, V343, P687
[7]  
MURRAY G, 1947, SURG GYNECOL OBSTET, V84, P665
[8]   RULES OF EVIDENCE AND CLINICAL RECOMMENDATIONS ON THE USE OF ANTITHROMBOTIC AGENTS [J].
SACKETT, DL .
CHEST, 1986, 89 (02) :S2-S3
[9]  
1992, CHEST S, V102, pS1
[10]  
1995, CHEST S, V108, pS1